Empowering Life Sciences with Advanced AI Solutions.
KnolScapes delivers end-to-end intelligence—covering disease epidemiology, pipeline and therapy tracking, biomarker insights, patient outcomes, market access, HTA monitoring, and competitive strategy
KnolScapes auto-updates with the latest research, trials, approvals, and competitive moves—keeping pharma teams current with real-time intelligence.
The platform adapts analyses by function (Clinical, HEOR, Regulatory, Market Access), region, and therapeutic project needs.
Generate industry standard SLRs, customized for your needs, through a few clicks by specifying a PICOS of your choice.
Validated by insutry experts for >95% coverage and accuracy.
Instantly update your SLR by changing the parameters of your review exercise.
Structured summaries across disease burden, treatment landscape, and clinical rationale
Precision medicine insights and companion diagnostic opportunities
Treatment effectiveness and real-world evidence analysis
Generate bespoke analysis across internal and relevant public data sources.
AI-powered analysis of medical literature and regulatory documents
Instantly update your analysis or convert into a repeated analysis module with a single click.
Knolens Navigator is designed to empower biopharmaceutical professionals with precise, actionable insights across various facets of Life Sciences research.
We've covered most of the common questions below.
Pienomial is an AI LifeScience company that transforms how professionals access and analyze data in support of their business goals. Whether you are in Big Pharma or a small biotech; or a service provider to the industry Pienomial can help you in a range of functions in your business.
Our flagship platform, Knolens, uses advanced AI to provide real-time, accurate insights from clinical trials, scientific publications, and more. Pienomial helps streamline product development and improve decision-making, empowering Life Sciences organizations to stay ahead in the industry.
Knolens uses a combination of multiple techniques including automated AI pipelines, human verification and domain expertise to ensure high relevance, accuracy and reliability of the data used in the analysis.
Knolens can easily integrate and analyze a wide range of structured and unstructured information including but not limited to FDA & EMA databases, PubMed and scientific journals, financial reports etc. Our customers can also, optionally, choose to leverage the power of our platform with their internal knowledge bases and data sources.
Yes. The Knolens platform is built for modularity and configurability. Our customers choose to use it in a way that provides them unique benefits specific to their business goals while leveraging the power of a stable, proven platform.
Book a free demo to see how KnolScapes streamlines scenario modeling for clinical, market access, competitive, and regulatory strategy—helping pharma teams optimize decisions.